# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001654954-21-006018
Filing Date
2021-05-19
Accepted
2021-05-19 10:03:57
Documents
20
Period of Report
2021-05-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | gtbp_8k.htm | 8-K | 25059
2 | PRESENTATION | gtbp_ex991.htm | EX-99.1 | 16619
3 | IMAGE | gtbp_ex991000.jpg | GRAPHIC | 22126
4 | IMAGE | gtbp_ex991001.jpg | GRAPHIC | 82280
5 | IMAGE | gtbp_ex991002.jpg | GRAPHIC | 52541
6 | IMAGE | gtbp_ex991003.jpg | GRAPHIC | 36872
7 | IMAGE | gtbp_ex991004.jpg | GRAPHIC | 47329
8 | IMAGE | gtbp_ex991005.jpg | GRAPHIC | 58153
9 | IMAGE | gtbp_ex991006.jpg | GRAPHIC | 59946
10 | IMAGE | gtbp_ex991007.jpg | GRAPHIC | 40642
11 | IMAGE | gtbp_ex991008.jpg | GRAPHIC | 45236
12 | IMAGE | gtbp_ex991009.jpg | GRAPHIC | 33112
13 | IMAGE | gtbp_ex991010.jpg | GRAPHIC | 39009
14 | IMAGE | gtbp_ex991011.jpg | GRAPHIC | 46583
15 | IMAGE | gtbp_ex991012.jpg | GRAPHIC | 49848
16 | IMAGE | gtbp_ex991013.jpg | GRAPHIC | 43406
17 | IMAGE | gtbp_ex991014.jpg | GRAPHIC | 47155
18 | IMAGE | gtbp_ex991015.jpg | GRAPHIC | 38685
19 | IMAGE | gtbp_ex991016.jpg | GRAPHIC | 52254
20 | IMAGE | gtbp_ex991017.jpg | GRAPHIC | 22167
| Complete submission text file | 0001654954-21-006018.txt |  | 1170741

Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 21938746
SIC: 2834 Pharmaceutical Preparations